This is an application requesting funding for Years 36-40 of a long-standing, highly successful Institutional Training Grant that supports postdoctoral research training in transfusion medicine and benign hematology. Since the last competitive renewal in 2007, funded research at the BloodCenter of Wisconsin (BCW) has continued to increase, and faculty available to mentor fellows has increased to 32. Available research space has been roughly doubled by an addition to the Blood Research Institute that was completed in December 2006. An agreement has been negotiated with the Medical College of Wisconsin (MCW) under which BloodCenter physicians now constitute the Section of Benign Hematology in the Division of Hematology-Oncology. Together, these developments enhance basic research training opportunities, open new avenues for clinical/translational research, and provide training grant faculty with unprecedented access to residents and fellows who have an interest in research training. Research opportunities available to trainees cover a broad range of clinical and basic research subjects relevant to transfusion medicine and hematology, including Immunology, Vascular Biology/Hemostasis, Transfusion Medicine, Stem Cell Biology, and Clinical Research. The research training experience will be essentially full time. Trainees will be expected to gain a basic understanding of the disciplines in which they undertake their investigations, develop competency with a variety of research technologies, strengthen their grasp of their chosen research by taking selected courses in the graduate studies program of MCW, and develop the ability to conduct independent research. Time spent in fellowship training is regarded as one of several stages of professional development. Accordingly, additional tracks will be offered to selected trainees, including the opportunity 1) to apply for a Clinical Investigator Development Award (K08) for continued mentoring, 2) to apply for independent grant support, and 3) for those oriented toward a career in transfusion medicine, an opportunity for further training as a junior member of BloodCenter's medical staff. Ultimately, trainees are expected to pursue academic or alternate careers in transfusion medicine, hematology, or closely related fields.

Public Health Relevance

Transfusion Medicine and Benign Hematology are important, but under-subscribed, areas of medicine. This application to renew BloodCenter of Wisconsin's long-standing training grant proposes to combine strengths in basic and translational research relevant to these disciplines with a faculty that has a long record of successful mentorship to create a post-doctoral research training program with a record of accomplishment.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007209-40
Application #
9614299
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Chang, Henry
Project Start
1976-07-01
Project End
2019-11-30
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
40
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Bloodcenter of Wisconsin, Inc.
Department
Type
DUNS #
057163172
City
Milwaukee
State
WI
Country
United States
Zip Code
53233
Abel, Alex M; Tiwari, Aradhana A; Gerbec, Zachary J et al. (2018) IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells. Front Immunol 9:1168
Xin, Gang; Schauder, David M; Zander, Ryan et al. (2017) Two is better than one: advances in pathogen-boosted immunotherapy and adoptive T-cell therapy. Immunotherapy 9:837-849
Zander, Ryan; Cui, Weiguo (2017) The power of combining adoptive cell therapy (ACT) and pathogen-boosted vaccination to treat solid tumors. Hum Vaccin Immunother 13:2269-2271
Schloemer, Nathan J; Brickler, Molly; Hoffmann, Raymond et al. (2017) Administration of Dexrazoxane Improves Cardiac Indices in Children and Young Adults With Acute Myeloid Leukemia (AML) While Maintaining Survival Outcomes. J Pediatr Hematol Oncol 39:e254-e258
van Mens, Thijs E; Liang, Hai-Po H; Basu, Sreemanti et al. (2017) Variable phenotypic penetrance of thrombosis in adult mice after tissue-selective and temporally controlled Thbd gene inactivation. Blood Adv 1:1148-1158
Wood, Jeremy P; Baumann Kreuziger, Lisa M; Desai, Umesh R et al. (2016) Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins. Br J Haematol 175:123-32
Liang, Hai Po H; Kerschen, Edward J; Basu, Sreemanti et al. (2015) Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice. Blood 126:2415-23
Liang, Hai Po H; Kerschen, Edward J; Hernandez, Irene et al. (2015) EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice. Blood 125:2845-54
Wandersee, Nancy J; Maciaszek, Jamie L; Giger, Katie M et al. (2015) Dietary supplementation with docosahexanoic acid (DHA) increases red blood cell membrane flexibility in mice with sickle cell disease. Blood Cells Mol Dis 54:183-8
Xu, Hao; Wandersee, Nancy J; Guo, YiHe et al. (2014) Sickle cell disease increases high mobility group box 1: a novel mechanism of inflammation. Blood 124:3978-81

Showing the most recent 10 out of 50 publications